Long-term clinical safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola vaccines: a prospective, multi-country, observational study by Puri, A, Pollard, AJ, Schmidt-Mutter, C, Lainé, F, PrayGod, G, Kibuuka, H, Barry, H, Nicolas, J-F, Lelièvre, J-D, Sirima, SB, Kamala, B, Manno, D, Watson-Jones, D, Gaddah, A, Keshinro, B, Luhn, K, Robinson, C, Douoguih, M

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical tr... by Barry, H, Mutua, G, Kibuuka, H, Anywaine, Z, Sirima, SB, Meda, N, Anzala, O, Eholie, S, Bétard, C, Richert, L, Lacabaratz, C, McElrath, MJ, de Rosa, S, Cohen, KW, Shukarev, G, Robinson, C, Gaddah, A, Heerwegh, D, Bockstal, V, Luhn, K, Leyssen, M, Douoguih, M, Thiébaut, R, Thiebaut, R